Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXAN for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where RITUXAN was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for RITUXAN

Side Effect Reports % Deaths Hosp.
Arthralgia 39 8.0% 1 19
Death 37 7.6% 37 4
Drug ineffective 37 7.6% 2 10
Off label use 34 7.0% 3 20
Infusion related reaction 33 6.8% 0 11
Pyrexia 33 6.8% 1 22
Dyspnoea 30 6.2% 0 16
Nausea 26 5.3% 0 11
Fatigue 25 5.1% 1 15
Rash 24 4.9% 1 11
Weight decreased 24 4.9% 1 9
Hypotension 23 4.7% 0 11
Pain 22 4.5% 2 8
Blood pressure increased 21 4.3% 0 3
Pneumonia 21 4.3% 3 14

Other Indications for RITUXAN

Rheumatoid arthritis (130) Product used for unknown indication (104) Chronic lymphocytic leukaemia (56) Non-hodgkin's lymphoma (25) B-cell lymphoma (24) Granulomatosis with polyangiitis (23) Lymphoma (13) Vasculitis (13) Immune thrombocytopenic purpura (12) Waldenstrom's macroglobulinaemia (9)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

RITUXAN Full Profile All Diffuse large b-cell lymphoma Drugs RITUXAN Demographics RITUXAN Timeline